Some physicians still shy away from using thiazides first-line for hypertension due to concerns about inducing diabetes
January 2007
Some physicians still shy away from using thiazides first-line for hypertension due to concerns about inducing diabetes.
It's true that thiazides increase the risk of hyperglycemia and new-onset diabetes.
But a new analysis of the large ALLHAT hypertension trial shows that this does NOT translate into a higher risk of CV events or death.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive